Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease

Rosenberg, 2011, Sarcopenia: origins and clinical relevance, Clin Geriatr Med, 27, 337, 10.1016/j.cger.2011.03.003 Dhillon, 2017, Pathogenesis and management of sarcopenia, Clin Geriatr Med, 33, 17, 10.1016/j.cger.2016.08.002 Cruz-Jentoft, 2010, Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people, Age Ageing, 39, 412, 10.1093/ageing/afq034 von Haehling, 2010, An overview of sarcopenia: facts and numbers on prevalence and clinical impact, J Cachexia Sarcopenia Muscle, 1, 129, 10.1007/s13539-010-0014-2 Shafiee, 2017, Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies, J Diabetes Metab Disord, 16, 21, 10.1186/s40200-017-0302-x De Fré, 2019, Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity?, Obes Rev, 20, 353, 10.1111/obr.12776 Wijarnpreecha, 2019, Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA, Eur J Gastroenterol Hepatol, 31, 1121, 10.1097/MEG.0000000000001397 Chung, 2019, Sarcopenia is significantly associated with presence and severity of nonalcoholic fatty liver disease, J Obes Metab Syndr, 28, 129, 10.7570/jomes.2019.28.2.129 Lee, 2015, Sarcopenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008–2011), J Hepatol, 63, 486, 10.1016/j.jhep.2015.02.051 Hong, 2014, Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study, Hepatology, 59, 1772, 10.1002/hep.26716 Peng, 2019, Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): the importance of sarcopenia definition, Clin Nutr, 38, 422, 10.1016/j.clnu.2017.11.021 Johnson, 2014, National health and nutrition examination survey: sample design, 2011-2014, Vital Health Stat 2, 1 2015 Ruhl, 2015, Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey, Aliment Pharmacol Ther, 41, 65, 10.1111/apt.13012 Angulo, 2007, The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD, Hepatology, 45, 846, 10.1002/hep.21496 Studenski, 2014, The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates, J Gerontol A Biol Sci Med Sci, 69, 547, 10.1093/gerona/glu010 Goff, 2014, 2013 ACC/AHA guideline on the assessment of cardiovascular risk, J Am Coll Cardiol, 63, 2935, 10.1016/j.jacc.2013.11.005 Araújo, 2019, Prevalence of optimal metabolic health in American adults: national health and nutrition examination survey 2009-2016, Metab Syndr Relat Disord, 17, 46, 10.1089/met.2018.0105 Whelton, 2018, 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults, J Am Coll Cardiol, 71, e127, 10.1016/j.jacc.2017.11.006 Wallace, 2004, Use and abuse of HOMA modeling, Diabetes Care, 27, 1487, 10.2337/diacare.27.6.1487 Rezaianzadeh, 2012, National Cholesterol Education Program Adult Treatment Panel III versus International Diabetic Federation definition of metabolic syndrome, which one is associated with diabetes mellitus and coronary artery disease?, Int J Prev Med, 3, 552 Wolter, 2007 Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, et al. National Health and Nutrition Examination Survey: analytic guidelines, 1999-2010. Vital Health Stat 2 2013;(161):1–24. Allison, 1995 Rubin, 2004 Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Cesari, 2014, Sarcopenia and physical frailty: two sides of the same coin, Front Aging Neurosci, 6, 192, 10.3389/fnagi.2014.00192 Brown, 2016, Sarcopenia and mortality among a population-based sample of community-dwelling older adults, J Cachexia Sarcopenia Muscle, 7, 290, 10.1002/jcsm.12073 Srikanthan, 2010, Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III, PLoS One, 5, e10805, 10.1371/journal.pone.0010805 Stenholm, 2008, Sarcopenic obesity: definition, cause and consequences, Curr Opin Clin Nutr Metab Care, 11, 693, 10.1097/MCO.0b013e328312c37d Kim, 2009, Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study, Int J Obes (Lond), 33, 885, 10.1038/ijo.2009.130 Wijarnpreecha, 2018, Sarcopenia and risk of nonalcoholic fatty liver disease: a meta-analysis, Saudi J Gastroenterol, 24, 12, 10.4103/sjg.SJG_237_17 Hu, 2017, The association between sarcopenia and non-alcoholic fatty liver disease, J Hepatol, 66, 243, 10.1016/j.jhep.2016.09.023 Abdulla, 2016, Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis, Diabetologia, 59, 44, 10.1007/s00125-015-3751-0 Zhai, 2017, The common mechanisms of sarcopenia and NAFLD, Biomed Res Int, 2017, 6297651, 10.1155/2017/6297651 Abbatecola, 2011, Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction, J Nutr Health Aging, 15, 890, 10.1007/s12603-011-0366-0 Kim, 2016, The association between sarcopenia and non-alcoholic fatty liver disease: potential pitfalls in non-invasive prediction models, J Hepatol, 64, 519, 10.1016/j.jhep.2015.10.031 Zhai, 2018, The relationship between NAFLD and sarcopenia in elderly patients, Can J Gastroenterol Hepatol, 2018, 5016091, 10.1155/2018/5016091 Hashimoto, 2016, The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes, Endocr J, 63, 877, 10.1507/endocrj.EJ16-0124 Bhanji, 2017, Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis, Hepatology, 66, 2055, 10.1002/hep.29420 Tandon, 2017, A practical approach to nutritional screening and assessment in cirrhosis, Hepatology, 65, 1044, 10.1002/hep.29003 Duarte-Rojo, 2018, Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list, Liver Transpl, 24, 122, 10.1002/lt.24958 Yu, 2018, Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis, BMC Gastroenterol, 18, 51, 10.1186/s12876-018-0776-0 Koo, 2017, Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis, J Hepatol, 66, 123, 10.1016/j.jhep.2016.08.019 Lee, 2016, Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008-2011), Hepatology, 63, 776, 10.1002/hep.28376 Petta, 2017, Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 45, 510, 10.1111/apt.13889